Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study.
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.
Value-Based Medicine and Integration of Tumor Biology.
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer. Cureus. 2016 Feb 26; 8(2):e513.
View in:
PubMed
authors with profiles
Ravi Salgia
Randy Sweis